Andreas Tiede
Jul 25, 2026, 07:39
Andreas Tiede: Emicizumab in Postpartum Acquired Hemophilia A
Andreas Tiede, Professor at Hannover Medical School, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Thrombosis and Haemostasis (JTH), adding:
”Acquired hemophilia A (AHA) is a serious condition that can occur after pregnancy.
Fortunately, we can prevent bleeding with emicizumab.
But is breastfeeding actually safe?”
Title: Transfer of emicizumab into breast milk in postpartum acquired hemophilia A
Authors: Simon Alexander Krooss, Tim Halling, Dirk Varnholt, Annika Klingberg, Korbinian Brand, Sonja Werwitzke, Heiner Wedemeyer, Christiane Dobbelstein, Andreas Tiede, Olga Oleshko
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 25, 2026, 08:08Abdulaziz (Omar) Badran: A Reminder That Morphology Still Matters in Modern Hematology
-
Jul 25, 2026, 07:55Syed Ali Shazif Baqari: Essential Guide to Blood Groups and Blood Component Compatibility
-
Jul 25, 2026, 07:39Flora Peyvandi: Understanding the Role of Fibrinogen Y in Recurrent Thrombosis
-
Jul 25, 2026, 07:25Melissa Hollo: Recognizing Champions of Patient Blood Management
-
Jul 25, 2026, 07:15Monifa Al Akoum: Combined Access Strategies Advance Pediatric Portal Vein Recanalization
-
Jul 25, 2026, 07:03Daniel Victor Ortigoza: Lower Bleeding Rates with Apixaban in Acute VTE Treatment
-
Jul 25, 2026, 06:43Ayuka King-Percival: How Lupus Anticoagulant Testing Works
-
Jul 24, 2026, 21:09Ifeanyichukwu Ifechidere: The Monitoring Dilemma in DOAC Therapy – Concentration vs. Real-Time Effect
-
Jul 24, 2026, 20:14Idris Syed: Presenting Our Omics and VTE Research at ISTH 2026